
Join to View Full Profile
3800 Reservoir Rd NWWashington, DC 20007
Phone+1 202-444-3736
Fax+1 202-444-0939
Dr. Doucette is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- St. George's University School of MedicineClass of 2015
Certifications & Licensure
- DC State Medical License 2018 - 2026
- MD State Medical License 2021 - 2026
- VA State Medical License 2023 - 2026
- NJ State Medical License 2024 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- A phase IIb study of selinexor in combination with daratumumab in patients with daratumumab-refractory multiple myeloma.Noa Biran, Eli Zolotov, David Vesole, Harsh Parmar, Pooja Phull
Haematologica. 2025-04-03 - Post-ASCT consolidation with elotuzumab, lenalidomide, and dexamethasone or elotuzumab, pomalidomide, and dexamethasone in high-risk and ultra-high-risk multiple myelo...Eli Zolotov, Maciej Kabat, Harsh Parmar, Palka Anand, Joshua Zenreich
Leukemia & Lymphoma. 2024-12-01 - 1 citationsVenetoclax-based induction therapy for primary plasma cell leukemia with high BCL-2 expression.Charalampos Charalampous, Kimberley Doucette, Aimee Chappell, David H Vesole
Leukemia & Lymphoma. 2024-12-01
Press Mentions
- Recent Advancements and Future Directions in Frontline Treatment of Multiple MyelomaJuly 11th, 2022
- Genetics of Donor Cell Leukemia in Acute Myelogenous Leukemia and Myelodysplastic SyndromeMarch 8th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: